ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ)
$0.2898 -0.0601 (-17.1763%)
Analysed ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) News Sources
This enGene Holdings Insider Increased Their Holding In The Last Year
19-08-2025
yahoo.com
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
11-11-2025
yahoo.com
enGene’s NMIBC gene therapy touts 63% complete response in pivotal trial
11-11-2025
clinicaltrialsarena.com
enGene Holdings (ENGN) Is Up 36.9% After Strong Phase 2 Bladder Cancer Gene Therapy Results
13-11-2025
yahoo.com
enGene CEO Pitches Detalimogene as Community-Friendly NMIBC Option, Teases Q2 LEGEND Data Update
15-03-2026
marketbeat.com
enGene Highlights 2026 Data Catalysts, BLA Plans for Bladder Cancer Gene Therapy at Barclays Conference
15-03-2026
marketbeat.com
enGene Shares Detalimogene NMIBC Trial Changes, FDA Endpoint Shift, and 2027 Approval Path at Conference
15-03-2026
marketbeat.com
Neumora depression drug fails; EnGene to cut 50% of staff
16-06-2026
biopharmadive.com
What is the current price of ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ)?
The current price of ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) is $0.2898.
ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) since the previous trading day is $-0.0601.
ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) since the previous trading day is -17.1763%.
What is the most recent average sentiment score for ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ)?
The most recent average sentiment score for ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ)?
The most recent sentiment for ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ) is .
SEC-8K** Filing Available For ENGENE HOLDINGS INC-28 (ENGNW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.